ArticleScientific reports2025

ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma.

Hehua Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.